or additional investing in proprietary trading Clause 8. Management company shall invest through proprietary trading when such investment is long term capital more than one year except in any of the
before investing or additional investing in proprietary trading Clause 8. Management company shall invest through proprietary trading when such investment is long term capital more than one year except in
หมายความถึงค่าธรรมเนียมที่ได้รับจากการเป็นนายหน้าซื้อขายหลักทรัพย์ (2) รายได้สำหรับการประกอบธุรกิจหลักทรัพย์ประเภทการค้าหลักทรัพย์ ให้หมายความถึงกำไรสุทธิ (net capital gain) ที่เกิดจากการค้าหลักทรัพย์ประเภท
Act B.E. 2546 (2003) and Clause 2 of the Notification of the Capital Market Supervisory Board No. TorThor/Nor/Khor. 87/2552 Re: Qualifications and Prohibited Characteristics of Directors and Executives
31, 2017 from the increase of paid-up capital which equivalent to Baht 32.35 million together with share premium from the exercising of ECF-W1 that expired in the year 2018 at the exercise price Baht
69.76% Total Liabilities 2,728.63 1,850.87 877.75 47.42% Issued and paid-up share capital 333.80 333.80 - - Premium on ordinary shares 587.17 587.17 - - Retained earnings – Appropriated 40.00 36.29 3.71
The transaction is an acquisition of shares in TBSP and is considered as the asset acquisition under the Capital Market Supervisory Board Re: Rules on Entering into Material Transactions Deemed as
considered as the asset acquisition under the Capital Market Supervisory Board Re: Rules on Entering into Material Transactions Deemed as Acquisition or Disposal of Assets. The Company is therefore required to
capital increase of Baht 55 million. Please be informed accordingly. Sincerely yours, Miss Suwarin Konthong Executive Vice President of Account and Finance DOD Biotech Public Company Limited
%) Current Liabilities 757.73 1,625.53 (867.80) (53.39%) Non-current Liabilities 1,042.99 1,103.10 (60.11) (5.45%) Total Liabilities 1,800.72 2,728.63 (927.91) (34.01%) Issued and paid-up share capital 333.80